Abstract
HDAC inhibitors are promising anticancer agents that induce cell cycle arrest and apoptosis. However, the role of HDACs in cancer progression, such as angiogenesis and metastasis, remains largely unexplored. Among various HDAC inhibitors, we demonstrate that TSA and SAHA upregulated the expression of angiostatic ADAMTS1 in A549 cells. HDAC6 inhibitor tubacin, and knockdown of HDAC6, also lead to ADAMTS1 upregulation. By reporter, DAPA, and ChIP assays, the proximal GC boxes were demonstrated to be essential for ADAMTS1 induction. Decreased binding of SP1 and HDAC6 to the ADAMTS1 promoter after TSA treatment was also seen. These data suggest the involvement of HDAC6 and SP1 in the HDACi-induced expression of angiostatic ADAMTS1.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
ADAM Proteins / biosynthesis*
-
ADAM Proteins / genetics
-
ADAMTS1 Protein
-
Angiostatic Proteins / biosynthesis*
-
Angiostatic Proteins / genetics
-
Antineoplastic Agents / pharmacology*
-
Cell Line, Tumor
-
Enzyme Inhibitors / pharmacology*
-
Histone Deacetylase 6
-
Histone Deacetylase Inhibitors*
-
Histone Deacetylases / genetics
-
Histone Deacetylases / metabolism
-
Humans
-
Hydroxamic Acids / pharmacology*
-
Promoter Regions, Genetic
-
Sp1 Transcription Factor / metabolism
-
Up-Regulation
-
Vorinostat
Substances
-
Angiostatic Proteins
-
Antineoplastic Agents
-
Enzyme Inhibitors
-
Histone Deacetylase Inhibitors
-
Hydroxamic Acids
-
Sp1 Transcription Factor
-
trichostatin A
-
Vorinostat
-
ADAM Proteins
-
ADAMTS1 Protein
-
ADAMTS1 protein, human
-
HDAC6 protein, human
-
Histone Deacetylase 6
-
Histone Deacetylases